Tepadina® from Riemser Pharma
AxxessBio has the exclusivity to distribute Tepadina® in multiple countries in Southeast Asia.
TEPADINA® is indicated in combination with other chemotherapy medicinal products,
- with or without total body irradiation (TBI), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (HPCT) in haematological diseases in adult and pediatric
- when high dose chemotherapy with HPCT support is appropriate for the treatment of solid tumors in adult and pediatric patients.
- Client: Riemser
- Speciality: Hematology
- Product: Tepadina®
- Learn more about
